• Alison C Zucca, Rob W Sanson-Fisher, Amy Waller, Mariko Carey, Alice Grady, and Lisa Mackenzie.
• University of Newcastle, Newcastle, NSW alison.zucca@newcastle.edu.au.
• Med. J. Aust. 2015 Nov 16;203(10):405-5.e7.

ObjectivesThe study examined: 1) the proportion of patients who received their preferred level of information about life expectancy; and 2) sociodemographic, clinical and psychological factors associated with patients' perceptions of whether they received too little, too much, or the right amount of information about life expectancy.DesignCross-sectional survey.SettingEleven large Australian medical oncology treatment centres.ParticipantsA total of 1431 medical oncology outpatients participated (81% consent rate). Eligible patients were approached between September 2012 and May 2014.Main Outcome MeasuresPatients indicated whether the information about life expectancy they received aligned with their preferences.ResultsAlmost one in four patients (24%) received too little information, 4% received too much, and 50% received all the information they wanted; 22% of patients neither wanted nor received information about life expectancy. Patients were more likely to receive too little information if they were not in remission (odds ratio [OR], 1.77), did not know their cancer stage at diagnosis (OR, 3.64), or were anxious (OR, 1.48) or depressed (OR, 1.48). Patients had greater odds of receiving too much information if they were younger (OR, 1.45), had more advanced cancer (OR, 2.01) or did not know their cancer stage at diagnosis (OR, 4.42).ConclusionsThat fact that 28% of cancer patients did not receive their desired level of information about life expectancy highlights the difficulties associated with discussing this sensitive topic. To ensure that life expectancy discussions correspond with patient preferences, clinicians should routinely ask patients whether they want to know this information, in what format, and at which level of detail.

27 keywords...

hide…